Document Detail


Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?
MedLine Citation:
PMID:  12757506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: Intracranial haemorrhage (ICH) of the fetus or newborn is a severe complication of fetal or neonatal alloimmune thrombocytopenia (FNAIT). In order to attain management decisions to prevent ICH, the risk of ICH in successive pregnancies with thrombocytopenia, with or without a history of ICH, must be established. MATERIALS AND METHODS: We performed a search of medline for ICH cases in untreated FNAIT pregnancies. After exclusion of cases with confounding factors, 24 reports, describing 62 pregnancies of 27 mothers, were eligible. In addition, two mothers with five pregnancies were included from our own case records. Observational studies were examined to estimate the risk of ICH in subsequent FNAIT pregnancies without a history of ICH. Finally, medline was searched for complication rates in the treatment of FNAIT pregnancies. RESULTS: In 52% of the ICH cases, a previous sibling suffered from ICH. The recurrence rate of ICH in the subsequent offspring of women with a history of FNAIT with ICH was 72%[confidence interval (CI): 46-98%] without inclusion of fetal deaths and 79% (CI: 61-97%) with inclusion of fetal deaths. In 48% of the ICH cases, the previous sibling had thrombocytopenia but not ICH. Population studies revealed an overall ICH risk in thrombocytopenic infants of 11% (CI: 0.8-23%) without inclusion of fetal deaths and 15% (CI: 1.5-19%) with inclusion of fetal deaths. Assuming occurrence in 48%, the risk of ICH in a subsequent pregnancy following a history of FNAIT without ICH, was estimated to be 7% (CI: 0.5-13%). Invasive treatment strategies carry a risk of 2.8% (CI: 1.2-4.4%) on complications. CONCLUSIONS: The number of eligible publications on ICH in untreated FNAIT pregnancies is strikingly limited. The recurrence rate is high. As sufficient data on successive FNAIT cases without ICH are lacking, the occurrence of ICH in pregnancies with thrombocytopenia, but without ICH in a previous sibling, cannot be predicted. We estimate this risk to be 7%. This risk must be balanced against the risk of interventions in treatment strategies.
Authors:
C M Radder; A Brand; H H H Kanhai
Related Documents :
16978616 - Association of cytochrome p450 1b1 polymorphism with first-trimester miscarriage.
17457096 - Antiretroviral therapy and premature delivery in diagnosed hiv-infected women in the un...
9486756 - Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibi...
11097796 - Does selenium reduce the risk of threatened preterm delivery associated with placental ...
11925406 - Reliability of serial urine hcg as a biomarker to detect early pregnancy loss.
15541856 - A flexible protocol for cryopreservation of pronuclear and cleavage stage embryos creat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Vox sanguinis     Volume:  84     ISSN:  0042-9007     ISO Abbreviation:  Vox Sang.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-21     Completed Date:  2004-03-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0413606     Medline TA:  Vox Sang     Country:  England    
Other Details:
Languages:  eng     Pagination:  318-25     Citation Subset:  IM    
Affiliation:
Department of Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands. C.M.Radder@LUMC.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Human Platelet / immunology
Blood Group Incompatibility / complications
Data Collection
Female
Fetal Death
Fetal Diseases
Humans
Infant, Newborn
Infant, Newborn, Diseases
Intracranial Hemorrhages / epidemiology,  etiology*
MEDLINE
Pregnancy
Pregnancy Complications, Hematologic / epidemiology,  etiology
Risk Assessment
Siblings
Thrombocytopenia / complications*,  epidemiology,  therapy
Chemical
Reg. No./Substance:
0/Antigens, Human Platelet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtration.
Next Document:  A novel DI*A allele without the Band 3-Memphis mutation in Amazonian Indians.